Cyclo Therapeutics Enters into Note Purchase Agreement with Rafael HoldingsCyclo Therapeutics, Inc. (NASDAQ:CYTH) announced today that it has entered into a Sixth Amended and Restated Note Purchase Agreement with Rafael Holdings, Inc., a Delaware cor
This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Cyclo Therapeutics’s 8K filing here. About Cyclo Therapeutics (Get Free Report) Cyclo Therapeutics, Inc, a clinical stage biotechnology company, engages in the development of cyclodextrin-based products for the treatment of neurodegenerative diseases. […]
More Stories
Voestalpine (OTCMKTS:VLPNY) Shares Down 4.5% – What’s Next?
Voestalpine AG (OTCMKTS:VLPNY – Get Free Report) was down 4.5% during mid-day trading on Wednesday . The company traded as...
Alfa Financial Software (LON:ALFA) Stock Price Down 1.6% – Should You Sell?
Alfa Financial Software Holdings PLC (LON:ALFA – Get Free Report) shares were down 1.6% during trading on Wednesday . The...
Grammer (ETR:GMM) Shares Up 1.4% – Time to Buy?
Grammer AG (ETR:GMM – Get Free Report) shot up 1.4% on Wednesday . The stock traded as high as €5.10...
Bowen Acquisition Corp Adjourns Meeting to Extend Business Combination Deadline
Bowen Acquisition Corp (NASDAQ:BOWNU) recently adjourned a general meeting scheduled for January 7, 2025, to deliberate on extending the deadline...
Arcadis (OTCMKTS:ARCAY) Shares Down 4.7% – Here’s What Happened
Arcadis NV (OTCMKTS:ARCAY – Get Free Report)’s share price dropped 4.7% on Friday . The company traded as low as...
ENDRA Life Sciences (NASDAQ:NDRA) Trading Down 0.3% – What’s Next?
ENDRA Life Sciences Inc. (NASDAQ:NDRA – Get Free Report) was down 0.3% during mid-day trading on Friday . The company...